Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chubb LtdCB · Entity 1639 | Director | May 21, 2026 | May 26, 2026 |
| Immatics N.V.IMTX · Entity 4718 | Director | June 16, 2026 | June 18, 2026 |
| electroCore, Inc.ECOR · Entity 6900 | Director | June 11, 2021 | June 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chubb Ltd
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 40,785.24 |
Reported balance
After 2026-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 681 · Balance 40,785.24 F1: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2: Total includes 629.95 shares credited at various times between April 2025 and April 2026 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. |
| Common SharesSEC Table I · non-derivative | Direct | 40,592.24 |
Reported balance
After 2026-05-21 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-05-21 · Tax withholding · Disposed 193 · Balance 40,592.24 F3: Common Shares being withheld in order to pay tax liability. |
| Common SharesSEC Table I · non-derivative | Direct | 40,014.24 |
Reported balance
After 2026-05-21 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-05-21 · Sale · Disposed 578 · Balance 40,014.24 F4: The Common Shares reported herein as being sold were sold at the same price. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date.
F2: Total includes 629.95 shares credited at various times between April 2025 and April 2026 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3.
F3: Common Shares being withheld in order to pay tax liability.
F4: The Common Shares reported herein as being sold were sold at the same price.
Immatics N.V.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.09 · Expires 2036-06-15 | Direct | 48,000 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 48,000 · Balance 48,000 F1: These Options vest 100% on the first anniversary of the grant date, June 16, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: These Options vest 100% on the first anniversary of the grant date, June 16, 2026.
electroCore, Inc.
Report date June 11, 2021 · Filed June 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2031-06-11 | Direct | 66,766 |
Reported balance
After 2021-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-11 · Grant · Acquired 66,766 · Balance 66,766 F1: The Deferred Stock Units vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting on or after January 1, 2022, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Deferred Stock Units vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting on or after January 1, 2022, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Oyster Point Pharma, Inc.
Report date January 03, 2023 · Filed January 04, 2023
Section 16 reporting ended · disclosed 2023-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-01-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-01-03 · Other · Disposed 18,063 · Balance 8,671 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. ("Purchaser"), a wholly owned subsidiary of Viatris, Inc. ("Viatris"), and Viatris, Purchaser commenced a tender offer (the "Offer") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer was consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the "Merger"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time")(continued in Footnote 2) F2: (other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the "Cash Amount") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the "Milestone Payment" and together with the Cash Amount, the "Per Share Price") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent. Row 2 · 2023-01-03 · Disposition to issuer · Disposed 8,671 · Balance 0 F3: This line item represents restricted stock units held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested restricted stock units was accelerated and each restricted stock unit was canceled in exchange for a cash payment equal to the Per Share Price less applicable tax withholdings. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.63 · Expires 2032-06-05 | Direct | 0 |
Reported balance
After 2023-01-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-03 · Disposition to issuer · Disposed 5,359 · Balance 0 F5: Each vested option that has an exercise price per share that is equal to or greater than the Per Share Price will be canceled for no consideration. F4: This line item represents stock options held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested stock options were accelerated, each such stock option became immediately exercisable and was canceled in exchange for a cash payment equal to the excess, if any, of the Per Share Price over the exercise price applicable to such stock option, less applicable tax withholdings. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.74 · Expires 2031-06-06 | Direct | 0 |
Reported balance
After 2023-01-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-03 · Disposition to issuer · Disposed 5,199 · Balance 0 F5: Each vested option that has an exercise price per share that is equal to or greater than the Per Share Price will be canceled for no consideration. F4: This line item represents stock options held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested stock options were accelerated, each such stock option became immediately exercisable and was canceled in exchange for a cash payment equal to the excess, if any, of the Per Share Price over the exercise price applicable to such stock option, less applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. ("Purchaser"), a wholly owned subsidiary of Viatris, Inc. ("Viatris"), and Viatris, Purchaser commenced a tender offer (the "Offer") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer was consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the "Merger"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time")(continued in Footnote 2)
F2: (other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the "Cash Amount") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the "Milestone Payment" and together with the Cash Amount, the "Per Share Price") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent.
F3: This line item represents restricted stock units held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested restricted stock units was accelerated and each restricted stock unit was canceled in exchange for a cash payment equal to the Per Share Price less applicable tax withholdings.
F4: This line item represents stock options held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested stock options were accelerated, each such stock option became immediately exercisable and was canceled in exchange for a cash payment equal to the excess, if any, of the Per Share Price over the exercise price applicable to such stock option, less applicable tax withholdings.
F5: Each vested option that has an exercise price per share that is equal to or greater than the Per Share Price will be canceled for no consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 20:47 UTC | Immatics N.V. IMTX · Entity 4718 | GrantStock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $9.09 | $0.00 |
DisclosureSEC source: 0000950103-26-009243 · ownership.xml · derivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2036-06-15 F1 · derivative.exercise_date: These Options vest 100% on the first anniversary of the grant date, June 16, 2026. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:15 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 578 | $329.53 | $190,468.34 |
DisclosureSEC source: 0001193125-26-239332 · ownership.xml · nonDerivative · entry 3 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,014.24 F4 · price: The Common Shares reported herein as being sold were sold at the same price. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:15 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 193 | $330.26 | $63,740.18 |
DisclosureSEC source: 0001193125-26-239332 · ownership.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,592.24 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:15 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 681 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239332 · ownership.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,785.24 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 629.95 shares credited at various times between April 2025 and April 2026 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 14:45 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 538 | $287.56 | $154,707.28 |
DisclosureSEC source: 0001213900-25-055471 · ownership.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,474.29 F1 · price: The price reported above has been rounded to the nearest cent. Read SEC document |
| May 15, 2025 Filed May 16, 2025 22:56 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 180 | $292.05 | $52,569.00 |
DisclosureSEC source: 0001213900-25-045010 · ownership.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,012.29 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 15, 2025 Filed May 16, 2025 22:56 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-045010 · ownership.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,192.29 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 249.6 shares credited at various times between October 2024 and April 2025 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 15:17 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 261 | $287.49 | $75,034.89 |
DisclosureSEC source: 0001213900-24-075871 · ownership.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,171.69 F1 · balance_after: Total includes 138.08 shares credited in July 2024 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Chubb Limited long-term incentive plan, which meets the requirements of Rule 16b-3. Read SEC document |
| May 17, 2024 Filed May 20, 2024 14:01 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 716 | $269.70 | $193,105.20 |
DisclosureSEC source: 0001213900-24-044948 · marketforms-65969.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,294.61 Read SEC document |
| May 16, 2024 Filed May 17, 2024 16:36 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 239 | $264.88 | $63,306.32 |
DisclosureSEC source: 0001213900-24-044598 · marketforms-65928.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,010.61 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 16, 2024 Filed May 17, 2024 16:36 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 718 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-044598 · marketforms-65928.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,249.61 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 598.38 shares credited at various times between July 2023 and April 2024 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| July 28, 2023 Filed Aug 14, 2023 16:18 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 750 | $208.39 | $156,292.50 |
DisclosureSEC source: 0001209191-23-045534 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,933.23 F1 · price: The sale price reported above has been rounded to the nearest whole cent. Read SEC document |
| May 17, 2023 Filed May 19, 2023 13:43 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 233 | $198.93 | $46,350.69 |
DisclosureSEC source: 0001209191-23-030871 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,683.23 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 17, 2023 Filed May 19, 2023 13:43 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-030871 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,916.23 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 621.64 shares credited at various times between July 2022 and April 2023 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:02 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,199 | Not disclosed Strike: $17.74 | Not disclosed |
DisclosureSEC source: 0001209191-23-001059 · doc4.xml · derivative · entry 4 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,199 shares Expires 2031-06-06 F5 · price: Each vested option that has an exercise price per share that is equal to or greater than the Per Share Price will be canceled for no consideration. F4 · derivative.exercise_date: This line item represents stock options held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested stock options were accelerated, each such stock option became immediately exercisable and was canceled in exchange for a cash payment equal to the excess, if any, of the Per Share Price over the exercise price applicable to such stock option, less applicable tax withholdings. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:02 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,359 | Not disclosed Strike: $3.63 | Not disclosed |
DisclosureSEC source: 0001209191-23-001059 · doc4.xml · derivative · entry 3 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,359 shares Expires 2032-06-05 F5 · price: Each vested option that has an exercise price per share that is equal to or greater than the Per Share Price will be canceled for no consideration. F4 · derivative.exercise_date: This line item represents stock options held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested stock options were accelerated, each such stock option became immediately exercisable and was canceled in exchange for a cash payment equal to the excess, if any, of the Per Share Price over the exercise price applicable to such stock option, less applicable tax withholdings. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:02 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | Disposition to issuerCommon Stock | 8,671 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-001059 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: This line item represents restricted stock units held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested restricted stock units was accelerated and each restricted stock unit was canceled in exchange for a cash payment equal to the Per Share Price less applicable tax withholdings. F3 · price: This line item represents restricted stock units held by the Reporting Person. Upon the Merger, which constituted a "change of control" under the Issuer's Outside Director Compensation Policy, vesting of the Reporting Person's outstanding unvested restricted stock units was accelerated and each restricted stock unit was canceled in exchange for a cash payment equal to the Per Share Price less applicable tax withholdings. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:02 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | OtherCommon Stock | 18,063 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-001059 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,671 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. ("Purchaser"), a wholly owned subsidiary of Viatris, Inc. ("Viatris"), and Viatris, Purchaser commenced a tender offer (the "Offer") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer was consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the "Merger"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the "Effective Time")(continued in Footnote 2) F2 · price: (other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the "Cash Amount") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the "Milestone Payment" and together with the Cash Amount, the "Per Share Price") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:44 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | GrantStock Option (Right to Buy) · Derivative | 5,359 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001209191-22-035057 · doc4.xml · derivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,359 Underlying: Common Stock · 5,359 shares Expires 2032-06-05 F3 · derivative.exercise_date: The shares underlying the option vest as to one-twelfth (1/12th) of the shares on July 6, 2022 and monthly thereafter on the same day of the month as the grant date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:44 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | GrantCommon Stock | 3,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035057 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,734 F1 · kind: Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · shares: The shares underlying the RSU will vest on June 6, 2023, but will vest fully on the date of the next annual stockholder meeting held after the date of grant if not fully vested on such date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date. Read SEC document |
| May 20, 2022 Filed May 23, 2022 16:41 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 500 | $203.49 | $101,745.00 |
DisclosureSEC source: 0001209191-22-031272 · doc4.xml · nonDerivative · entry 3 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,339.59 F4 · price: The sale price reported above has been rounded to the nearest cent. Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:41 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 271 | $203.88 | $55,251.48 |
DisclosureSEC source: 0001209191-22-031272 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,839.59 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:41 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-031272 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,110.59 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 622.89 shares credited at various times between July 2021 and April 2022 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 13:24 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 2,944 | $186.20 | $548,172.80 |
DisclosureSEC source: 0001209191-21-052701 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,555.7 F1 · price: The sale price reported above has been rounded to the nearest cent. Read SEC document |
| June 11, 2021 Filed Jun 16, 2021 00:06 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantDeferred Stock Units · Derivative | 66,766 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-014483 · ownership.xml · derivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,766 Underlying: Common Stock · 66,766 shares Expires 2031-06-11 F1 · derivative.exercise_date: The Deferred Stock Units vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting on or after January 1, 2022, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. Read SEC document |
| June 07, 2021 Filed Jun 10, 2021 00:43 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | GrantStock Option (Right to Buy) · Derivative | 5,199 | $0.00 Strike: $17.74 | $0.00 |
DisclosureSEC source: 0001209191-21-039331 · doc4.xml · derivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,199 Underlying: Common Stock · 5,199 shares Expires 2031-06-06 F3 · derivative.exercise_date: The shares underlying the option vest as to one-twelfth (1/12th) of the shares on July 7, 2021 and monthly thereafter on the same day of the month as the grant date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date. Read SEC document |
| June 07, 2021 Filed Jun 10, 2021 00:43 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | GrantCommon Stock | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039331 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,161 F1 · kind: Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · shares: The shares underlying the RSU will vest on June 7, 2022, but will vest fully on the date of the next annual stockholder meeting held after the date of grant if not fully vested on such date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date. Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:10 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 431 | $166.16 | $71,614.96 |
DisclosureSEC source: 0001209191-21-035233 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,499.7 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:10 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 1,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-035233 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,930.7 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 806.44 shares credited at various times between July 2020 and April 2021 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 14:52 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 1,000 | $165.36 | $165,360.00 |
DisclosureSEC source: 0001209191-21-009982 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,041.26 F1 · price: The sale price reported above has been rounded to the nearest cent. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 11:29 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | GrantCommon Stock | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054575 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,695 F1 · security: This security represents restricted stock units (the "RSUs"). Each RSU represents a contingent right to received one share of common stock of the Issuer. F3 · shares: 1/8 of the RSUs will vest in eight equal monthly installments beginning on the first month following the grant date on the same day of the month until the Company's Annual Meeting of Stockholders to be held in 2021; provided, however, if all of such RSUs are not fully vested at the Company's next Annual Meeting of Stockholders, any such remaining RSUs will vest on such date, in each case, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 11:29 UTC | Oyster Point Pharma, Inc. OYST · Entity 15903 | GrantCommon Stock | 15,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054575 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,295 F1 · security: This security represents restricted stock units (the "RSUs"). Each RSU represents a contingent right to received one share of common stock of the Issuer. F2 · shares: 1/3 of the RSUs will vest in three equal annual installments, with 1/3 vesting on the one (1) year anniversary of October 8, 2020, and one-third (1/3) of the RSUs vesting annually thereafter on October 8, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date. Read SEC document |
| June 12, 2020 Filed Jun 17, 2020 00:40 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantDeferred Stock Units · Derivative | 112,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-011292 · ownership.xml · derivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2030-06-12 F1 · derivative.exercise_date: The Deferred Stock Units vest in full on the earlier of (i) the close of business on the day before the next annual meeting of stockholders following the date hereof, and (ii) the date immediately prior to a change of control, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 15:12 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 309 | $104.61 | $32,324.49 |
DisclosureSEC source: 0001209191-20-031579 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,041.26 F3 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 20, 2020 Filed May 22, 2020 15:12 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 1,721 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-031579 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,350.26 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F2 · balance_after: Total includes 397.44 shares credited at various times between January 2020 and April 2020 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan, which meets the requirements of Rule 16b-3. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 18:05 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 1,500 | $151.12 | $226,680.00 |
DisclosureSEC source: 0001209191-19-056292 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,231.82 F1 · price: The sale price reported above has been rounded to the nearest whole cent. F2 · balance_after: Total includes 345.08 shares credited at various times between July 2019 and October 2019 to the reporting person's deferred stock account pursuant to the dividend investment provisions of a Chubb Limited long-term incentive plan which meets the requirements of Rule 16b-3. Read SEC document |
| June 07, 2019 Filed Jun 12, 2019 00:49 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantStock Option (Right to Buy) · Derivative | 63,291 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0000899243-19-016553 · doc4.xml · derivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,291 Underlying: Common Stock · 63,291 shares Expires 2029-06-08 F1 · derivative.exercise_date: The options vest upon the close of business on the day before the next annual meeting of stockholders following the date hereof. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:58 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 316 | $145.62 | $46,015.92 |
DisclosureSEC source: 0001209191-19-031285 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,386.74 F2 · kind: Common Shares being withheld in order to pay tax liability. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:58 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 1,236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-031285 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,702.74 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 16:17 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 341 | $141.86 | $48,374.26 |
DisclosureSEC source: 0001209191-19-029204 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 0 F1 · price: The sale price reported above has been rounded to the nearest whole cent. Read SEC document |
| May 09, 2019 Filed May 13, 2019 16:17 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 1,659 | $141.87 | $235,362.33 |
DisclosureSEC source: 0001209191-19-029204 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,466.74 F1 · price: The sale price reported above has been rounded to the nearest whole cent. F2 · balance_after: Total includes 376.94 shares credited at various times between January 2019 and April 2019 to the reporting person's deferred stock account pursuant to the dividend investment provisions of a Chubb Limited long-term incentive plan which meets the requirements of Rule 16b-3. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 20:27 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 1,200 | $133.27 | $159,924.00 |
DisclosureSEC source: 0001209191-18-060351 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,748.8 F1 · price: The Common Shares reported herein as being sold were sold at a range of between $133.27 and $133.28 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. F2 · balance_after: Total includes 387.32 shares credited at various times between July 2018 and October 2018 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan which meets the requirements of Rule 16b-3 Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 13:19 UTC | Chubb Ltd CB · Entity 1639 | SaleCommon Shares | 920 | $130.86 | $120,389.36 |
DisclosureSEC source: 0001209191-18-035980 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,561.48 Read SEC document |
| May 17, 2018 Filed May 21, 2018 19:20 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 307 | $134.45 | $41,276.15 |
DisclosureSEC source: 0001209191-18-031741 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,481.48 F2 · kind: Common Shares being withheld in order to pay tax liability. F3 · balance_after: Total includes 654.34 shares credited at various times between July 2017 and April 2018 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan which meets the requirements of Rule 16b-3. Read SEC document |
| May 17, 2018 Filed May 21, 2018 19:20 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 1,264 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-031741 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,134.14 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. Read SEC document |
| May 18, 2017 Filed May 22, 2017 15:22 UTC | Chubb Ltd CB · Entity 1639 | Tax withholdingCommon Shares | 321 | $138.56 | $44,477.76 |
DisclosureSEC source: 0001209191-17-034126 · doc4.xml · nonDerivative · entry 2 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,870.14 F2 · kind: Common Shares being withheld in order to pay tax liability. F3 · balance_after: Total includes 343.90 shares credited at various times between January 2017 and April 2017 to the reporting person's deferred stock account pursuant to the dividend investment provisions of the Plan which meets the requirements of Rule 16b-3. Read SEC document |
| May 18, 2017 Filed May 22, 2017 15:22 UTC | Chubb Ltd CB · Entity 1639 | GrantCommon Shares | 1,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-034126 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,847.24 F1 · kind: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. F1 · price: Restricted stock award granted as director fees under a Chubb Limited long-term incentive plan (the "Plan"), which meets the requirements of Rule 16b-3. Such restricted stock will vest on the day of the next annual Chubb Limited shareholders meeting, assuming the reporting person is a director of Chubb Limited on such date. Read SEC document |
| November 11, 2016 Filed Nov 16, 2016 16:34 UTC | Chubb Ltd CB · Entity 1639 | GiftCommon Shares | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-150403 · doc4.xml · nonDerivative · entry 1 ATIEH MICHAEL G · CIK 0001072501 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,620.24 F1 · balance_after: Total includes 364 shares credited at various times between July 2016 and October 2016 to the reporting person's deferred stock account pursuant to the dividend investment provisions of a Chubb Limited long-term incentive plan which meets the requirements of Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.